400 related articles for article (PubMed ID: 11531016)
1. Expression pattern of hybrid phenotype in adult acute lymphoblastic leukemia.
Nakase K; Kita K; Miwa H; Nishii K; Shiku H; Nasu K; Dohy H; Kyo T; Kamada N; Tsutani H
Cancer Detect Prev; 2001; 25(4):394-405. PubMed ID: 11531016
[TBL] [Abstract][Full Text] [Related]
2. [Bone marrow immunophenotypes of 112 cases of lymphoid system malignant diseases].
Ling JY; Sun XF; Yan SL; He LR; Zhen ZJ; Xia Y
Ai Zheng; 2007 Apr; 26(4):418-22. PubMed ID: 17430665
[TBL] [Abstract][Full Text] [Related]
3. Leukemia-associated marker combinations in acute leukemia suitable for detection of minimal residual disease.
Babusíková O; Mesárosová A; Koníková M; Kusenda J; Glasová M; Klobusická M
Neoplasma; 1993; 40(5):275-81. PubMed ID: 8272155
[TBL] [Abstract][Full Text] [Related]
4. Characterization of CD34+, CD13+, CD33- cells, a rare subset of immature human hematopoietic cells.
Gaipa G; Coustan-Smith E; Todisco E; Maglia O; Biondi A; Campana D
Haematologica; 2002 Apr; 87(4):347-56. PubMed ID: 11940478
[TBL] [Abstract][Full Text] [Related]
5. In vivo and in vitro expression of myeloid antigens on B-lineage acute lymphoblastic leukemia cells.
Hara J; Kawa-Ha K; Yumura-Yagi K; Kurahashi H; Tawa A; Ishihara S; Inoue M; Murayama N; Okada S
Leukemia; 1991 Jan; 5(1):19-25. PubMed ID: 1705635
[TBL] [Abstract][Full Text] [Related]
6. Frequent but nonrandom expression of myeloid markers on de novo childhood acute lymphoblastic leukemia.
Abdelhaleem M
Exp Mol Pathol; 2007 Aug; 83(1):138-41. PubMed ID: 17434163
[TBL] [Abstract][Full Text] [Related]
7. [Cellular immunophenotypes in 97 adults with acute leukemia].
Piedras J; López-Karpovitch X; Cárdenas MR
Rev Invest Clin; 1997; 49(6):457-64. PubMed ID: 9528305
[TBL] [Abstract][Full Text] [Related]
8. [Immunologic characteristics and prognosis of acute myeloid leukemia M1].
Zhao F; Chen Y
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2007 Aug; 15(4):687-91. PubMed ID: 17708783
[TBL] [Abstract][Full Text] [Related]
9. Characterization of CD13 and CD33 surface antigen-negative acute myeloid leukemia.
Kraguljac N; Marisavljevic D; Jankovic G; Radosevic N; Pantic M; Donfrid M; Miletic N; Boskovic D; Colovic M
Am J Clin Pathol; 2000 Jul; 114(1):29-34. PubMed ID: 10884796
[TBL] [Abstract][Full Text] [Related]
10. CD56+CD7+ stem cell leukemia/lymphoma with D2-Jdelta1 rearrangement.
Yoshida T; Kimura N; Sawada H; Suematsu E; Nagano M; Akiyoshi T; Motomura S; Kikuchi M; Nishimura J; Tamura K
Intern Med; 1999 Jul; 38(7):547-55. PubMed ID: 10435360
[TBL] [Abstract][Full Text] [Related]
11. The reliability of cytoplasmic CD3 and CD22 antigen expression in the immunodiagnosis of acute leukemia: a study of 500 cases.
Janossy G; Coustan-Smith E; Campana D
Leukemia; 1989 Mar; 3(3):170-81. PubMed ID: 2465463
[TBL] [Abstract][Full Text] [Related]
12. The immunophenotype of 325 adult acute leukemias: relationship to morphologic and molecular classification and proposal for a minimal screening program highly predictive for lineage discrimination.
Thalhammer-Scherrer R; Mitterbauer G; Simonitsch I; Jaeger U; Lechner K; Schneider B; Fonatsch C; Schwarzinger I
Am J Clin Pathol; 2002 Mar; 117(3):380-9. PubMed ID: 11888077
[TBL] [Abstract][Full Text] [Related]
13. Aberrant myeloid marker expression in precursor B-cell and T-cell leukemias.
Suggs JL; Cruse JM; Lewis RE
Exp Mol Pathol; 2007 Dec; 83(3):471-3. PubMed ID: 17963747
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of immunophenotype and leukemia associated immunophenotype in 610 patients with acute myeloid leukemia].
Liu YR; Wang YZ; Chen SS; Chang Y; Fu JY; Li LD; Wang H; Yu H; Jiang B; Huang XJ
Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):731-6. PubMed ID: 18457262
[TBL] [Abstract][Full Text] [Related]
15. Lineage differentiation of canine lymphoma/leukemias and aberrant expression of CD molecules.
Wilkerson MJ; Dolce K; Koopman T; Shuman W; Chun R; Garrett L; Barber L; Avery A
Vet Immunol Immunopathol; 2005 Jul; 106(3-4):179-96. PubMed ID: 15963817
[TBL] [Abstract][Full Text] [Related]
16. [The induction of differentiation of myeloid antigen positive acute lymphoblastic leukemia by phorbol ester (TPA) or GM-CSF].
Takeuchi H; Katayama I
Rinsho Ketsueki; 1990 May; 31(5):639-46. PubMed ID: 2203920
[TBL] [Abstract][Full Text] [Related]
17. Aberrant CD2 expression in precursor-B acute lymphoblastic leukemia of childhood.
Dunphy CH; Chu JY
Am J Hematol; 1996 Jul; 52(3):224-6. PubMed ID: 8756094
[TBL] [Abstract][Full Text] [Related]
18. Philadelphia-chromosome-positive, monosomy 7 biphenotypic acute mixed lineage leukemia in adults: a pluripotent stem cell disorder.
Hamaguchi H; Nakamura Y; Nagata K; Shiba S; Arimura H; Muroga K; Miyake S; Ohkawa Y; Morio T
Leukemia; 1993 Nov; 7(11):1752-8. PubMed ID: 7901455
[TBL] [Abstract][Full Text] [Related]
19. Automatic lineage assignment of acute leukemias by flow cytometry.
Verwer BJ; Terstappen LW
Cytometry; 1993 Nov; 14(8):862-75. PubMed ID: 7507022
[TBL] [Abstract][Full Text] [Related]
20. Myeloid antigen, CD13, CD14, and/or CD33 expression is restricted to certain lymphoid neoplasms.
Nakase K; Kita K; Shiku H; Tanaka I; Nasu K; Dohy H; Kyo T; Tsutani H; Kamada N
Am J Clin Pathol; 1996 Jun; 105(6):761-8. PubMed ID: 8659452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]